Schizophrenia, bipolar disorder, major depressive disorder and other severe mental illnesses affect a greater proportion of patients with chronic kidney disease (CKD).

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...